Clinical Trials Browser

Completed × Stem Cell Transplantation × 30 days × Clear all

NCT03477539 2026-03-09

Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

Phase 2 Completed

49 enrolled 15 charts

Multiple Myeloma